1Gurbel PA, Bliden KP, Hiatt BL, et al. Clopidogrel for coronary stenting: response variability, drug resistance, and the effect of pretreatment platelet reactivity[ J]. Circulation, 2003, 107 (23) :2908 -2913.
2Serebmany VL, Steinhubl SR, Hennekens CH. Are antiplatelet effects of clopidogrel inhibited atorvastatin? A research question formulated but not yet adequately tested[ J]. Circulation, 2003, 107(12) :1568 - 1569.
3Patti G, Colonna G, Pasceri V, et al. Randomized trial of loading dose of clopidgrel foe reductiong pf peri procedural mryocardial infarction in patients undergoing coronary intervention: result from the ARMYDA-2 (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty) study [ J ]. Circulation, 2005, 111 ( 16 ) : 2099 - 2106.
5Lau WC, Gurbel PA, Watkins PB, et al. Contribution of hepatic cy- tochrome P450 3A4 metabolic activity to the phenomenon of clopi- dog relresistance [ J]. Circulation ,2004,109 (2) : 166 - 171.
6Lau WC, Waskell LA, Watkins PB, et al. Atorvastatin reduces the ability of clopidogrel to inhibit platelet aggregation : a new drug-drug interaction [ J ]. Circulation , 2003, 107 ( 1 ) : 32 - 37.
7Neubauer H, Gtinesdogan B, Hanefeld C, et al. Lipophilic statins in- terfere with the inhibitory effects of clopidogrel on platelet func- tion--a flow cytometry study[ J]. Eur Heart J, 2003,24 ( 19 ) :1744 - 1749.
8Saw J, Brennan DM, Steinhubl BR, et al. Lack of evidence of a clo- pidogrel-statin interaction in the CHARISMA trial [ J ]. J Am Coil Cardiol, 2007,50 ( 4 ) :291 - 295.
9Gorchakova O, yon Beckerath N, Gawaz M, et al. Antiplatelet effects of a 600 mg loading dose of clopidogrel are not attenuated in patients receiving atorvastatin or simvastatin for at least 4 weeks prior to coro- nary artery stenting[J]. Eur Heart J,2004,25 (21) :1898 - 1902.
10Montalescot G, Sideris G, Meuleman C, et al. A randomized comparison of high clopidogrel loading doses in patients with non-ST-segment elevation acute coronary syndromes: the Albion (Assessment of the Best Loading Dose of Clopidogrel to Blunt Platelet Activation, Inflammation and Ongoing Necrosis) trial [J]. J Am Coil Cardiol, 2006, 48(5): 931-8.
